Definitive Contract 75N91022C00026
Award Date 8/25/22
Potential Completion Date 9/14/23
Potential Value $400K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Valley Cottage, NY 10989, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Celartia, Inc., a small disadvantaged business, for the development of a fully automated system for cell therapy processing. The contract has a period of performance from September 13, 2021 to June 12, 2022 and a ceiling value of $393,312. The contract was awarded under a total small business set-aside. The original...
- This is a $399,062 firm-fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Avoneaux Medical Institute, LLC for the development of spatial micro-purification technology. The contract was set aside for small businesses and is part of the NCI's broader SBIR program, which funds research and development in support of the NIH and CDC's mission needs. The original solicitation sought proposals on a range of cancer-related topics, including alternatives to cell...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled "Non-Invasive Subtyping of Aggressive Tumor and Its Environment" as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC...
- This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). The contract was awarded to Veloxai LLC, a self-certified small disadvantaged business, to develop an automatic treatment planning system for high-dose rate brachytherapy for cervical cancer in low-resource settings. The contract was set aside for total small businesses and has a completion date of September 14,...
- This federal contract award is for the Small Business Innovation Research (SBIR) program. The contract was awarded to Kiyatec Inc., a for-profit organization, with a ceiling value of $1,704,285.58. The contract is a definitive contract with a firm fixed price pricing type. The ultimate completion date is November 1, 2019, and the award date was September 30, 2015. The contract was set aside for small businesses. The funding agency is the National Cancer Institute, a civilian agency. The contract...
- This federal contract award for $389,535 was made to Electronic Biosciences, Inc., a small business biotechnology company, by the National Cancer Institute (NCI) under the Small Business Innovation Research (SBIR) program. The contract is for the development of an "IDEAL AT-HOME PROSTATE SPECIFIC ANTIGEN (PSA) TESTING" solution, which aligns with NCI's mission to support innovative technologies for cancer diagnostics and prevention. The contract is a Firm Fixed Price, Definitive...
- <p>This is a $1,999,386.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Avoneaux Medical Institute, LLC, a veteran-owned limited liability company. The contract is for the development of spatial micropurification technology under SBIR Topic 403. The contract is a definitive, firm fixed-price contract with a period of performance ending on September 18, 2024.</p>
- This definitive contract from the National Institutes of Health's National Cancer Institute, valued at $398,001, was awarded to Ferrologix Inc. to address Topic 397 under a Small Business Innovation Research Program Phase I solicitation. Specifically, the prime contractor will conduct research and development to functionally close the purification and elution of untouched T cells using cleavable magnetic beads with ratcheting cytometry. This firm fixed price contract has a period of...